ResearchKomen is the largest non-governmental funding source of breast cancer research in the world, with $12.2 million dedicated to researchers at Providence Cancer Center and Oregon Health & Science University Knight Cancer Institute. The latest research grants awarded in Oregon:
|Komen Research Awards
|OHSU Knight Cancer Institute Investigator||Year||Amount|
|Providence Medical Center Investigator
|OHSU Knight Cancer Institute Investigator
| Joe Gray
|Komen Scholar Joe Gray, Ph.D. - Oregon Health & Science University Knight Cancer Institute
2016 Recipient - Received $400,000
Dr. Redmond received $400,000 to expand his work studying the role that genetics may plan in why HER2+ breast cancer patients eventually develop resistance to HER2+ -targeted therapies. Information from this work will help design and test new drug combinations to better optimize current treatments available for HER2+ breast cancer patients.
William Redmond, Ph.D. - Providence Portland Medical Center
2015 Recipient - Received $450,000
Dr. Redmond received $450,000 to understand the biological mechanisms that stop a patient’s immune system from fighting breast cancer. He will help develop new immunotherapeutic approaches, such as a vaccine, that will potentially destroy breast cancer cells throughout the body, providing better treatment options for women with metastatic breast cancer.
Komen Scholar Joe Gray, Ph.D. - Oregon Health & Science University Knight Cancer Institute
2014 Recipient - Received $200,000
Dr. Gray received $200,000 in continued funding to understand if the local environment in the breast tissue (including the oxygen levels) could cause some HER2-positive breast cancer tumors to become resistant to treatment. This information will be used to design more specific drug combinations that will counter these effects.
|The Gray Family Fund supports national advanced breast cancer research. Donate to the Gray Family Fund.